Communication
From Machine Learning to Natural Product Derivatives that Selectively Activate Transcription Factor PPARγ
Article first published online: 30 DEC 2009
DOI: 10.1002/cmdc.200900469
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Rupp, M., Schroeter, T., Steri, R., Zettl, H., Proschak, E., Hansen, K., Rau, O., Schwarz, O., Müller-Kuhrt, L., Schubert-Zsilavecz, M., Müller, K.-R. and Schneider, G. (2010), From Machine Learning to Natural Product Derivatives that Selectively Activate Transcription Factor PPARγ. ChemMedChem, 5: 191–194. doi: 10.1002/cmdc.200900469
Publication History
- Issue published online: 26 JAN 2010
- Article first published online: 30 DEC 2009
- Manuscript Revised: 10 DEC 2009
- Manuscript Received: 15 NOV 2009
Funded by
- DFG. Grant Number: MU 987/4-1
Keywords:
- drug design;
- machine learning;
- natural products;
- NMR;
- virtual screening
Graphical Abstract

Advanced kernel-based machine learning methods enable the identification of innovative bioactive compounds with minimal experimental effort. Comparative virtual screening revealed that nonlinear models of the underlying structure–activity relationship are necessary for successful compound picking. In a proof-of-concept study a novel truxillic acid derivative was found to selectively activate transcription factor PPARγ.

1860-7187/asset/2452_left.gif?v=1&s=4110e7425ac5e40773dfb0778cfefa62f1594507)
1860-7187/asset/2452_right.gif?v=1&s=8458ea1f15af84217b579501ed7d7733bef04a94)
